文献速递肝病

肝硬化急性失代偿患者外周血中表达HLA-G的抑制性CD4+ T细胞扩增

Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis.
PubMed 文献 · Gut · 2021-08-03

该研究通过流式细胞术检测20例健康对照和98例肝硬化患者(28例稳定期、20例慢性失代偿、50例急性失代偿)外周血CD4+HLA-G+ T细胞比例,发现急性失代偿患者中该抑制性细胞亚群扩增,与疾病严重程度、感染并发症及不良预后相关,其由Kupffer细胞来源的IL-35诱导,并通过CTLA-4和HLA-G途径抑制T细胞反应。

要点

  • 肝硬化急性失代偿患者外周血CD4+HLA-G+CTLA-4+IL-35+抑制性T细胞扩增,与疾病严重程度和不良预后相关。
  • Kupffer细胞是IL-35的重要来源,可诱导CD4+ T细胞表达HLA-G。
  • 该细胞通过CTLA-4介导T细胞功能受损,并下调Th17相关细胞因子。

核心结论

  • 肝硬化急性失代偿患者外周血中存在由细胞因子驱动的外周来源抑制性CD4+HLA-G+ T细胞扩增,可能参与免疫麻痹。

研究设计与样本

  • 研究纳入20例健康对照和98例肝硬化患者(28例稳定期、20例慢性失代偿、50例急性失代偿),采用流式细胞术检测CD4+HLA-G+ T细胞比例及免疫表型。
  • 通过NanoString技术和抑制实验分析分选CD4+HLA-G+细胞的转录和功能特征,并用体外阻断实验研究IL-35的作用。
  • 采用免疫组化和原代人Kupffer细胞培养评估IL-35的细胞来源,并使用中和抗体探索HLA-G介导的T细胞抑制通路。

主要发现

  • 急性失代偿患者中CD4+HLA-G+CTLA-4+IL-35+免疫抑制性细胞群扩增,与疾病严重程度、临床病程、感染并发症和不良结局相关。
  • 转录组分析排除这些细胞为胸腺来源的调节性T细胞。
  • 免疫组化和体外培养显示Kupffer细胞是IL-35的强效来源,可诱导HLA-G+表型。
  • 这些细胞通过CTLA-4介导T细胞反应受损,并伴随HLA-G驱动的Th17相关细胞因子下调。

临床怎么用

  • 在肝硬化急性失代偿患者中,监测外周血CD4+HLA-G+ T细胞比例可能有助于评估免疫抑制状态和预后。
  • 针对IL-35或HLA-G/CTLA-4通路的干预可能为改善肝硬化急性失代偿患者的免疫麻痹提供新思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Identifying components of immuneparesis, a hallmark of chronic liver failure, is crucial for our understanding of complications in cirrhosis. Various suppressor CD4+ T cells have been established as potent inhibitors of systemic immune activation. Here, we establish the presence, regulation and mechanism of action of a suppressive CD4+ T cell subset expressing human leucocyte antigen G (HLA-G) in patients with acute decompensation of cirrhosis (AD). DESIGN: Flow cytometry was used to determine the proportion and immunophenotype of CD4+HLA-G+ T cells from peripheral blood of 20 healthy controls (HCs) and 98 patients with cirrhosis (28 with stable cirrhosis (SC), 20 with chronic decompensated cirrhosis (CD) and 50 with AD). Transcriptional and functional signatures of cell-sorted CD4+HLA-G+ cells were delineated by NanoString technology and suppression assays, respectively. The role of immunosuppressive cytokine interleukin (IL)-35 in inducing this population was investigated through in vitro blockade experiments. Immunohistochemistry (IHC) and cultures of primary human Kupffer cells (KCs) were performed to assess cellular sources of IL-35. HLA-G-mediated T cell suppression was explored using neutralising antibodies targeting co-inhibitory pathways. RESULTS: Patients with AD were distinguished by an expansion of a CD4+HLA-G+CTLA-4+IL-35+ immunosuppressive population associated with disease severity, clinical course of AD, infectious complications and poor outcome. Transcriptomic analyses excluded the possibility that these were thymic-derived regulatory T cells. IHC analyses and in vitro cultures demonstrate that KCs represent a potent source of IL-35 which can induce the observed HLA-G+ phenotype. These exert cytotoxic T lymphocyte antigen-4-mediated impaired responses in T cells paralleled by an HLA-G-driven downregulation of T helper 17-related cytokines. CONCLUSION: We have identified a cytokine-driven peripherally derived suppressive population that may contribute to immuneparesis in AD.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Khamri W, Gudd C, Liu T, et al. Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis. Gut. 2021. PMID: 34344786. doi:10.1136/gutjnl-2021-324071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。